Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20240221061070N2Phase 3Completed
Phase 3, randomised, double-blind trial of pethidine, bupivacaine and Normal Saline-Benha University in postanesthetic shivering (PAS) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Occurrence of shivering. Started Jan 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20240221061070N2.